Trinity Biotech (TRIB) Invested Capital (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Invested Capital for 8 consecutive years, with $72.4 million as the latest value for Q4 2024.
- Quarterly Invested Capital rose 40574.16% to $72.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $86.3 million through Dec 2024, changed N/A year-over-year, with the annual reading at $72.4 million for FY2024, 40574.16% up from the prior year.
- Invested Capital hit $72.4 million in Q4 2024 for Trinity Biotech, up from $178000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $72.4 million in Q4 2024 to a low of $178000.0 in Q4 2023.
- Historically, Invested Capital has averaged $22.5 million across 4 years, with a median of $8.8 million in 2020.
- Biggest five-year swings in Invested Capital: tumbled 98.71% in 2023 and later skyrocketed 40574.16% in 2024.
- Year by year, Invested Capital stood at $3.8 million in 2020, then soared by 259.28% to $13.7 million in 2022, then crashed by 98.71% to $178000.0 in 2023, then soared by 40574.16% to $72.4 million in 2024.
- Business Quant data shows Invested Capital for TRIB at $72.4 million in Q4 2024, $178000.0 in Q4 2023, and $13.7 million in Q4 2022.